Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Therefore, it is important to follow the manufacturers directions regarding the amount of bacteriostatic water needed for each specific product when reconstituting peptides
It does not replace a hormone optimization program, a longevity peptide cycle, or a metabolic peptide for weight loss
However, long-term human safety trials are lacking, so usage should be approached with caution
| Agent | FDA Approval | Mean Weight Loss (RCT) | Route | |---|---|---|---| | Semaglutide 2.4 mg (Wegovy) | Yes (2021) | 14.9% at 68 weeks (STEP-1, N=1,961) [9] | Subcutaneous weekly | | Tirzepatide 15 mg (Zepbound) | Yes (2023) | 20.9% at 72 weeks (SURMOUNT-1, N=2,539) [11] | Subcutaneous weekly | | AOD-9604 1 mg oral | No | ~2.8 kg at 12 weeks (Phase IIb, N=300 approx.) [1] | Oral (not currently compounded) | The weight-loss magnitude from the single Phase IIb AOD-9604 trial is substantially smaller than what STEP-1 (semaglutide) and SURMOUNT-1 (tirzepatide) demonstrated in larger, longer trials
Inositol Inositol breaks down fats to keep them from accumulating
US$ 25.30
US$ 21.39
US$ 22.18
US$ 23.98
US$ 24.33
